SFX by Ex Libris Inc.

Title:	A common mass scale for satellite galaxies of the Milky Way
Source:	Nature [0028-0836] Strigari, Louis yr:2008

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Manji, Husseini K K. "Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders." Nature reviews. Drug discovery 7.5 (2008): 426-37.
description	2.	Manji, Husseini K K. "Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of alpha-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors." Biological Psychiatry 63.4 (2007): 349-52.
description	3.	Manji, H. "A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression." Archives of general psychiatry 63.8: 856-64.
description	4.	Butterfield, D Allan A. "The glutamatergic system and Alzheimer's disease - Therapeutic implications." CNS drugs 17.9 (2003): 641-652.
description	5.	Pittenger, C. "Stress, depression, and neuroplasticity: A convergence of mechanisms." Neuropsychopharmacology 33.1 (2008): 88-109.
description	6.	drevets, C. "Subgenual prefrontal cortex abnormalities in mood disorders." Nature 386.6627 (1997): 824-827.
description	7.	Berman, R M M. "Antidepressant effects of ketamine in depressed patients." Biological Psychiatry 47.4 (2000): 351-4.
description	8.	Charney, David A K. "A double-blind, placebo-controlled study of memantine in the treatment of major depression." The American journal of psychiatry 163.1 (2005): 153-5.
description	9.	Zarate, Carlos A. "Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial." Biological psychiatry 71.11 (2012): 939-3223.
description	10.	Koike, H. "Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression." Behavioural brain research 224.1 (2011): 107-111.
description	11.	Diazgranados, N. "A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression." Archives of general psychiatry 67.8 (2010): 793-802.
description	12.	Aan Het Rot, M. "Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression." Biological psychiatry 67.2 (2009): 139-145.
description	13.	Garcia, Lêda S. "Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus." Progress in neuro-psychopharmacology & biological psychiatry 32.1 (2007): 140-144.
description	14.	Li, N. "mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists." Science 329.5994 (2010): 959-964.
description	15.	Krystal, John H H. "Ketamine and the potential role for rapid-acting antidepressant medications." Swiss medical weekly 137.15-16 (2007): 215-6.
description	16.	Krishnan, Vaishnav, V. "The molecular neurobiology of depression." Nature 455.7215 (2008): 894-902.
description	17.	ongur, D. "Glial reduction in the subgenual prefrontal cortex in mood disorders." Proceedings of the National Academy of Sciences of the United States of America 95.22 (1998): 13290-5.
description	18.	Price, J L L. "Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders." Molecular psychiatry 3.3 (1998): 220-6.
description	19.	Maeng, S. "The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects." Current Psychiatry Reports 9.6 (2008): 467-74.
description	20.	Mayberg, Helen S S. "Deep brain stimulation for treatment-resistant depression." Neuron 45.5 (2005): 651-660.